FKBP2 and pulmonary fibrosis: Taken together, cyclophilin A, FKBP12, FKBP10, and, FKBP13 have shown an important role in the pathogenesis of lung fibrosis; however, further research should be conducted to strengthen their therapeutic target potential in lung fibrosis treatment.